MERJURIE RICKLEFS: Open Payments
NPI 1821693094 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 28 payments from 4 companies in 2025. Trend: 2023 $249 · 2024 $574 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $198 |
| ABBVIE INC. | 12 | $181 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Axsome Therapeutics, Inc. | 2 | $50 |
Products named: CAPLYTA, VRAYLAR, FANAPT, Auvelity.
Industry payments across ID — which companies pay providers there.
